Tag: FGFR-inhibitor
First oral drug shows promise in childhood achondroplasia: Phase 3 trial results
A Phase 3 trial published in the New England Journal of Medicine shows that oral infigratinib increases growth velocity by…
Submit Your Paper to GMJ
No APC until January 2027.